Koehler Pharmaceuticals (Beijing) Ltd. is a Joint Venture company established in 2020 by Dr. Franz Köhler Chemie GmbH with partners in China. The company will centrally manage and operate the business of CUSTODIOL for cardiac- and transplant surgery in the Chinese market, aim at providing better, faster and more attentive services to Chinese hospitals and clinicians, as well as advanced support for Chinese patients’ health.

CUSTODIOL is worldwide used and known as the original HTK-Bretschneider solution, which is also the standard as cardioplegic and organ protective solution in thoracic surgery and organ transplantation. It has been accepted and used in more than 90 countries worldwide and greatly appreciated in variety of different markets throughout the world.

The company will continue the mission of Dr. Franz Koehler Chemie GmbH in regarding to promoting medical science and research, dedicating to conduct further research on myocardial protection and organ preservation together with clinical experts in China, and introducing more outstanding products for intensive care medicine into the China market.    view more >